Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract …
WEBPharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing. News and analysis on clinical trial services and contract research and development. Pfizer withdraws sickle cell disease drug Oxbryta amid safety concerns. The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease ...
Premier Research: holistic approach benefits development
WEBOct 6, 2020 — Holistic design starts off with designing a target product profile that considers the end goal early in the development planning. Also, part of a successful holistic approach, Sharif suggested, is asking thoughtful, appropriate questions at the outset, making sure to consider outcome-focused impactful issues at every stage of development.
About us - outsourcing-pharma.com
WEBAbout us. , the specialist B2B media, business intelligence and events group dedicated to helping businesses succeed. Our diverse portfolio of category-leading brands serves a global audience of almost 5M monthly users, supported by sector-specific insights & research, up-to-the-minute digital media and cutting-edge customer solutions.
Digital revolution transforming drug development: West Pharma
WEBOct 18, 2021 — Digital revolution transforming drug development: West Pharma. News and analysis on clinical trial services and contract research and development. A leader from the drug development and manufacturing firm talks about the ways in which advanced digital tools stand to revolutionize the pharma field. The pharmaceutical industry is rapidly ...
Multi-national studies call for informed approach: Firma
WEBJan 25, 2022 — 40% of Firma’s supported trials include IP administration for multiple administration routes, including IV infusion. 98% of the over 133,000 completed home trial visits by Firma HTPs have been conducted within the protocol visit windows. Firma has supported approximately 15 studies in the oncology therapeutic area in the last 5 years …
Sanofi unveils EUROAPI as name of new API company
WEBJan 14, 2021 — Sanofi has unveiled EUROAPI as the name of its new European active pharmaceutical ingredients (API) company. Additionally, the firm has appointed Karl Rotthier as its future CEO. According to Sanofi, the new company stands to be the largest API organization in the European Union, with projected sales of approximately €1b …
Connecting patients to sites, info key to study success: StudyKIK
WEBMar 9, 2022 — Technology that better connects patients and sites, and provides them with useful information about their participation, can make a huge difference. Matt Miller, CEO of StudyKIK (a patient recruitment and retention tech company acquired by Syneos Health in 2021), spoke with Outsourcing-Pharma about the company’s mission to streamline ...
Augmented reality in the pharmaceutical industry
WEBDec 14, 2017 — Last week, Jersey City, NJ-headquartered Apprentice $2.5m in venture funding for its augmented reality (AR) solution. Dubbed, Affinity, the solution is designed to improve productivity, audit readiness quality, and safety within pharmaceutical lab and research environments. Angelo Stracquatanio, CEO and co-founder of Apprentice told …
McKesson completes RxCrossroads acquisition
WEBJan 8, 2018 — McKesson Corporation has completed its acquisition of RxCrossroads to support customer needs beyond channel distribution as the industry faces increasing challenges. The supply chain management solutions company purchased RxCrossroads – a Kentucky-based specialty solutions provider – from CVS Health Corporation in a deal …
When choosing a pharmacovigilance partner, pick a safety …
WEBOct 4, 2021 — Finding a research partner with the pharmacovigilance (PV) capabilities to take a project to the next step can be challenging. Outsourcing-Pharma discussed the topic with two leaders, who offer advice and outline the benefits of finding a capable, fitting company: Nina Patel Lahanis, associate vice president of safety science, Eversana.